### In vitro / physico-chemical Data <a id="invitro-and-physico-chemical-data"></a>

A literature search was performed to collect available information on physicochemical properties of tefibazumab. The obtained information from literature is summarized in the table below. 

| **Parameter** | **Unit** | **Value** | Source                       | **Description**                                              |
| :------------ | -------- | --------- | ---------------------------- | ------------------------------------------------------------ |
| MW            | g/mol    | 150000    | [Lobo 2004](#5-references)   | Molecular weight                                             |
| r             | nm       | 5.34      | [Taylor 1984](#5-references) | Hydrodynamic solute radius                                   |
| Kd (FcRn)     | µM       | 0.63      | [Zhou 2003](#5-references)   | Dissociation constant for binding of a human IgG1 antibody to human FcRn at pH 6 |

### PK Data <a id="PK-data"></a>

Published clinical PK data on tefibazumab in healthy adults were used.

| Publication                  | Description                                                  |
| :--------------------------- | :----------------------------------------------------------- |
| [Reilly 2005](#5-references) | The plasma concentration–time profiles after single dose 15 min i.v. infusion of 2, 5, 10, or 20 mg/kg body weight in healthy adults were used. |

